<DOC>
	<DOCNO>NCT01776463</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability pharmacokinetics ( include food effect ) single multiple dos Z-360 healthy Japanese subject .</brief_summary>
	<brief_title>A Healthy Subject Study With Z-360 Placebo</brief_title>
	<detailed_description>This single centre , randomize , double-blind , placebo-controlled , parallel-group , food effect study.This three part study . The purpose first part ( Part 1 ) evaluation safety , tolerability , pharmacokinetics single ascend dos Z-360.The second part ( Part 2 ) evaluation pharmacokinetics food effect Z-360.The third part ( Part 3 ) evaluation safety , tolerability , pharmacokinetics multiple ascend dos Z-360 .</detailed_description>
	<criteria>1 . Healthy male subject 20 49 year age inclusive 2 . Body mass index ( BMI ) within range 17.6 26.4 kg/m2 inclusive 3 . The subject capable give write informed consent prior admission study 1 . History presence drug hypersensitivity , drug dependence , narcotic dependence alcohol dependence 2 . History presence disease digestive , liver , kidney , blood , cardiovascular , neuropsychiatric may affect participation result study 3 . Positive test Hepatitis B surface antigen , Hepatitis C antibody , HIV antigen antibody Serological test syphilis 4 . Use medication within 1 week prior dose 5 . Received investigational drug new active ingredient within 16 week prior dose study receive investigational drug clinical study within 12 week 6 . Whole blood collection exceed 200 mL within 4 week , apheresis within 2 week , blood withdrawal exceed 400 mL within 12 week ( blood donation , etc ) prior dose 7 . Others , patient unfit study determine attend physician</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Z-360</keyword>
	<keyword>Japanese</keyword>
	<keyword>pK</keyword>
</DOC>